Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Coronavirus Infections »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Coronavirus Envelope Proteins < Coronavirus Infections < Coronavirus OC43, Human  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1029.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000125 (2021) Okechukwu S. Ogah ; Ejiroghene M. Umuerri ; Adewole Adebiyi ; Olanike A. Orimolade ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen SliwaSARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
000221 (2021) A A Kamalov ; V Yu Mareev ; Ya A. Orlova ; A G Plisyk ; Z A Akopyan ; Yu V. Mareev ; E A Mershina ; Yu L. Begrambekova ; P V PakhomovHydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.
000235 (2021) Claudia N. Paiva ; Daniel V. TauskHydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
000236 (2021) Bruno Luís De Castro AraujoHydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
000237 (2021) Caleb P. Skipper ; David R. BoulwareHydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
000239 (2021) Anusuya Bhattacharyya ; Phulen Sarma ; Hardeep Kaur ; Bikash MedhiHydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
000283 (2021) L. Ratiani ; S. Gegechkory ; K. Machavariani ; T. Shotadze ; T. Sanikidze ; N. IntskirveliTHE PECULIARITY OF COVID- 19 GENOME AND THE CORONAVIRUS RNA TRANSLATION PROCESS AS APOTENTIAL TARGET FOR ETIOTROPIC MEDICATIONSWITH ADENINE AND OTHER NUCLEOTIDE ANALOGUES (REVIEW).
000301 (2021) Van Thuan HoangComment to Sands et al. - No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
000327 (2021) Prof Imad M. Tleyjeh ; Haytham TlayjehPerceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of "goals of care".
000356 (2021) Peter Horby ; Nicholas J. White ; Martin J. LandrayHydroxychloroquine in Hospitalized Patients with Covid-19. Reply.
000357 (2021) Alexis Lacout ; Christian Perronne ; Valere LounnasHydroxychloroquine in Hospitalized Patients with Covid-19.
000397 (2020) Petar M. MitrasinovicPrediction of Single Point Mutations in Human Coronavirus and Their Effects on Binding to 9-O-Acetylated Sialic Acid and Hidroxychloroquine.
000452 (2021) Bugra Han Egeli ; Jeffrey A. Sparks ; Alfred H J. Kim ; Jean W. LiewHydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?
000663 (2021) N. Dauby ; L. Catteau ; J. Hautekiet ; M. Montourcy ; E. Bottieau ; E. Goetghebeur ; D. Van BeckhovenReply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'.
000744 (2020) Peter Yamoah ; Thelma Mpoku Alalbila ; Varsha Bangalee ; Frasia OosthuizenCoronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion.
000751 (2021) Sanjay Kumar Mishra ; Timir TripathiOne year update on the COVID-19 pandemic: Where are we now?
000756 (2020) S. Chandrashekara ; Prakruthi Jaladhar ; Shruti Paramshetti ; Veena Ramachandran ; Sayid Fahad Nizar ; Devaraj KoriPost COVID Inflammation Syndrome: Different Manifestations Caused by the Virus.
000757 (2020) S B Bavdekar ; A. Chandrasekaran ; R P Govindarajan ; S. Malik ; S. Bajaj ; Y. Javeri ; V. NiranjanPhysician Health in the Times of COVID-19.
000773 (2020) Moa-Lina Haller ; Marie-Eve Brunner ; Hervé Olivier Zender[Intensive care unit treatment for patients suffering from COVID-19: the Neuchâtel experience].
000796 (2020) Seung-Geun Lee ; Geun U. Park ; Yeo Rae Moon ; Kihoon SungClinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database.
000799 (2020) Z. Ahmadinejad ; R. Assari ; N. Ayoobi Yazdi ; S-H Mazloomi ; P. Javanshayani ; H. Khalili Afousi ; V. ZiaeeCOVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Coronavirus Infections" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Coronavirus Infections" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Coronavirus Infections
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021